GLB1 and Parkinson disease: This finding, as well as the discovery of other promising early PD biomarkers in urine including DPP7/2, ENPEP, WFDC2, JPH3, GLB1, and others, should be replicated in additional cohorts with multiple detection approaches to understand the full utility of urine protein testing in PD.